Solari Capital Deploys $350 Million, With Bitcoin as One Sleeve of Three
AJ Scaramucci's Solari Capital has come out of stealth with $350 million already working across artificial intelligence, biotech and Bitcoin. The Bitcoin position is framed as a direct hedge against monetary debasement, and the sizing of that sleeve is the number allocators will actually care about.
Solari Capital came out of stealth with $350 million already deployed across three buckets: artificial intelligence, biotech and Bitcoin. Founder AJ Scaramucci calls the thesis "programmable reality," and the pitch is that computing power is compounding fast enough to turn biology, matter, intelligence and finance into systems you can program.
Broad mandate. Familiar shape, too, for allocators who've spent three years working out where a digital asset sleeve belongs next to venture exposure.
The Bitcoin piece is the one worth reading twice. Scaramucci treats it as a core bet against monetary debasement. Not a wager on the application layer. Not a proxy for risk appetite. That framing matters, because it puts Bitcoin in the same drawer as gold, and it puts the asset in direct competition with the concentration risk most equity books are carrying right now, which is the Magnificent Seven. The risk-adjusted case remains intact, though position sizing warrants review.
Scarcity versus abundance is the whole argument. Gold has held a monetary premium for a century. Bitcoin has a supply cap. Both stand apart from companies that can issue more shares whenever the board feels like it.
The rest of the fund's coverage list runs wide. Programmable matter, embodied AI, humanoid robotics, lessons from Waymo's rollout curve, frontier labs and open source, collectibles, and the market for dinosaur fossils, where a T-Rex specimen apparently trades as an asset class. Fission Labs, tokenized private shares and the future of IPOs round things out.
No investment committee signs off on that entire list. And that's the useful tension here.
Institutional adoption is measured in basis points allocated, not headlines generated. A $350 million vehicle spanning AI, biotech and Bitcoin tells you the general partner has conviction across all three. It doesn't tell you the weight of each. For a family office running a mandate with a defined drawdown tolerance, the sizing of the Bitcoin sleeve is the only figure that changes the portfolio math, and it's the only figure that gets discussed in a fiduciary review.
Deploying capital is the headline. Splitting it's the mandate. Watch for the allocation breakdown, because that's where the conversation actually starts.